Cargando…
Sofosbuvir and daclatasvir
Autores principales: | Hessel, Marleen H. M., Cohen, Adam F., Rissmann, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111747/ https://www.ncbi.nlm.nih.gov/pubmed/27198488 http://dx.doi.org/10.1111/bcp.13011 |
Ejemplares similares
-
Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019) -
Acute Interstitial Nephritis Associated with Sofosbuvir and Daclatasvir
por: Ashraf, Taha, et al.
Publicado: (2017) -
A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
por: Shabani, M., et al.
Publicado: (2021) -
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016) -
Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats
por: Ibrahim, Mohamed A., et al.
Publicado: (2018)